Schuler M - Search Results

1

[Interferon-alpha in therapy of malignant hemoblastoses].

Schuler M, Aulitzky WE, Schneller F, Peschel C, Huber C. Schuler M, et al. Internist (Berl). 1995 Dec;36(12):1133-8. Internist (Berl). 1995. PMID: 8567218 Review. German. No abstract available.

2

[Gene therapy of solid tumors].

Kuball J, Huber C, Schuler M. Kuball J, et al. Among authors: schuler m. Internist (Berl). 2001 Oct;42(10):1321-7. doi: 10.1007/s001080170054. Internist (Berl). 2001. PMID: 11688151 Review. German. No abstract available.

3

Interleukins. Clinical pharmacology and therapeutic use.

Aulitzky WE, Schuler M, Peschel C, Huber C. Aulitzky WE, et al. Among authors: schuler m. Drugs. 1994 Nov;48(5):667-77. doi: 10.2165/00003495-199448050-00002. Drugs. 1994. PMID: 7530625 Review.

4

Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.

Schönbohn H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, Aulitzky WE. Schönbohn H, et al. Among authors: schuler m. Ann Hematol. 1995 Oct;71(4):161-8. doi: 10.1007/BF01910312. Ann Hematol. 1995. PMID: 7578521

5

Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.

Schuler M, Huber C, Peschel C. Schuler M, et al. Ann Hematol. 1995 Aug;71(2):57-63. doi: 10.1007/BF01699247. Ann Hematol. 1995. PMID: 7654854 Review.

6

Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer.

Schuler M, Peschel C, Schneller F, Fichtner J, Färber L, Huber C, Aulitzky WE. Schuler M, et al. J Interferon Cytokine Res. 1996 Nov;16(11):903-10. doi: 10.1089/jir.1996.16.903. J Interferon Cytokine Res. 1996. PMID: 8938565 Clinical Trial.

7

Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.

Tretter T, Schuler M, Schneller F, Brass U, Esswein M, Aman MJ, Huber C, Peschel C. Tretter T, et al. Among authors: schuler m. Cell Immunol. 1998 Oct 10;189(1):41-50. doi: 10.1006/cimm.1998.1360. Cell Immunol. 1998. PMID: 9758693

8

Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia--results of a phase-II trial.

Schneller F, Schuler M, Schumacher K, Thaler J, Peschel C, Huber C, Aulitzky W. Schneller F, et al. Among authors: schuler m. Ann Hematol. 1998 Nov;77(5):225-9. doi: 10.1007/s002770050447. Ann Hematol. 1998. PMID: 9858148 Clinical Trial.

9

Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.

Schuler M, Tretter T, Schneller F, Huber C, Peschel C. Schuler M, et al. Immunobiology. 1999 Feb;200(1):128-39. doi: 10.1016/s0171-2985(99)80038-2. Immunobiology. 1999. PMID: 10084701

10

IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.

Brass U, Tretter T, Schneller F, Schuler M, Huber C, Peschel C. Brass U, et al. Among authors: schuler m. J Interferon Cytokine Res. 1999 Apr;19(4):335-43. doi: 10.1089/107999099314036. J Interferon Cytokine Res. 1999. PMID: 10334384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,081 results

Search Page

Filters